Alnylam Pharmaceuticals
HealthcareBiotech & Pharma
HQ: Cambridge, USA
Investors: 1
A biopharmaceutical company focused on the discovery and development of RNA interference therapeutics.
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Blackstone | Current | - | - | Unknown |